Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.
复制标题
DOI:
10.1158/1055-9965.epi-12-1022
复制
发表时间:
2013-01
期刊:
影响因子:
--
通讯作者:
Caan BJ
中科院分区:
文献类型:
--
作者:
Kwan ML;Chen WY;Flatt SW;Weltzien EK;Nechuta SJ;Poole EM;Holmes MD;Patterson RE;Shu XO;Pierce JP;Caan BJ
Alcohol consumption is an established risk factor for incident breast cancer. However, its role in breast cancer prognosis remains unclear. We conducted an investigation of post-diagnosis alcohol consumption with recurrence and mortality among 9,329 breast cancer patients in the After Breast Cancer Pooling Project. Women were diagnosed from 1990-2006 with AJCC Stage I-III breast tumors from three prospective U.S. cohorts. Alcohol intake was assessed at cohort entry (mean 2.1 years post-diagnosis) using a food frequency questionnaire. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using delayed entry Cox proportional hazards models with adjustment for known prognostic factors. After a mean follow-up of 10.3 years, 1,646 recurrences and 1,543 deaths were ascertained. 5,422 women (58%) were considered drinkers (≥0.36 g/day of alcohol, ≥0.25 drinks/week) with a median of 5.3 g/day. Overall, compared with non-drinking, regular alcohol intake (≥6.0 g/day) was not associated with risk of recurrence (HR for 6-<12 g/day=1.03; 95% CI: 0.86, 1.24; HR for 12-<24 g/day=1.12; 95% CI: 0.93, 1.34; HR for ≥24 g/day=1.04; 95% CI: 0.84, 1.31). However, risk varied significantly by menopausal status (p for interaction<0.05). Postmenopausal women who regularly consumed alcohol (≥6.0 g/day) had increased risk of recurrence (HR=1.19; 95% CI: 1.01, 1.40). Alcohol intake was not associated with mortality. Regular alcohol consumption was not associated with breast cancer recurrence and total mortality overall, yet recurrence risk was only elevated in postmenopausal women. The association between alcohol intake and recurrence may depend on menopausal status at breast cancer diagnosis.